People struggling to pay for diabetes or obesity medications may soon get some relief.
A new study suggests that blockbuster drugs like Ozempic and Wegovy, which have skyrocketed in popularity but come with sky-high price tags, could potentially be manufactured for a fraction of their current costs.
